Content area

|
|

18F-FDG-PET/CT bidrager til diagnostik og behandlingsmonitorering af stråleinduceret angiosarkom

Forfatter(e)
Francesca Cucchi1, Jens Bülow1, Lene Simonsen1, Lotte Nedergaard2, Christian Haarmark3 & Ali Asmar1 1) Klinisk Fysiologisk og Nuklearmedicinsk Afdeling, Bispebjerg og Frederiksberg Hospital 2) Patologiafdelingen, Rigshospitalet 3) Klinisk Fysiologisk og Nuklearmedicinsk Afdeling, Herlev og Gentofte Hospital Ugeskr Læger 2017;179:V08160530
Reference: 
Ugeskr Læger 2017;179:V08160530
Blad nummer: 
Sidetal: 
2-3
18F-FDG PET/CT contributes to diagnostics and therapy monitoring of radiation-induced angiosarcoma
Angiosarcomas are rare, aggressive malignant mesenchymal tumours with a poor prognosis. Radiation therapy is an independent risk factor for the development of secondary angiosarcoma. The onset of angiosarcoma may resemble benign lesions, leading to delayed diagnosis. It has been suggested that 18F-fluorodeoxyglucose (FDG) PET/CT scan may be useful in the early diagnosis in differenti­ating angiosarcoma from benign lesions and in therapy monitoring. We report the utility of 18F-FDG PET/CT scan in the diagnosis and follow-up of radiation-induced angio­sarcoma in a patient previously treated for uterine cancer.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Hans Erik Brygger | 24/06
3 kommentarer
af Jennifer Vikre-Jørgensen | 22/06
2 kommentarer
af Susanne L. M. Bülow | 19/06
2 kommentarer
af Niels Ejnar Bie | 18/06
2 kommentarer
af Hanne Hermann | 17/06
1 Kommentar
af Julius Vindbjerg Nissen | 17/06
1 Kommentar
af Peter Tagmose Thomsen | 15/06
1 Kommentar